Ngokusebenzisa imijikelo eliqela yokhuphiswano ngaphezu kweshumi elinesibini elaziwayo le-IVD R&D kunye neenkampani zokuvelisa, uKonsung wawongwa malunga nezigidi ngezigidi zeerandi zenkxaso yeprojekthi esekwe kwiqonga lobugcisa bezinto eziphilayo ezomileyo nguFIND ngoSeptemba.Sityikitye isivumelwano sentsebenziswano ne-FIND ukudala iinkqubo zovavanyo lwezonyango kumazwe ehlabathi anengeniso ephantsi kunye nephakathi , kunye nokuphucula ngokudibeneyo umgangatho wezixhobo zovavanyo lwezonyango kwihlabathi jikelele.
ISiseko se-Innovative New Diagnostics (FIND), iqabane elinobuchule loMbutho wezeMpilo weHlabathi, ngumbutho wehlabathi ongenzi nzuzo osebenza nabaphandi abangaphezu kwama-200, amaziko, oorhulumente, kunye nemibutho kwihlabathi jikelele ukuqhubela phambili uphuhliso kunye nokuveliswa kwezinto ezintsha. iitekhnoloji zokuxilonga ezixhasa uphononongo lwezifo, ulawulo kunye nokuthintela.
Yasekwa ngo-2013, iJiangsu Konsung Bio-medical and Science Technology Co., Ltd. yinkampani yetekhnoloji entsha egxile ekuxilongweni kwe-in vitro, amayeza osapho, amayeza aphathwayo, amayeza esilwanyana sasekhaya kunye nokwandisa itekhnoloji yetekhnoloji yezempilo.I-Konsung ikuphela komthengisi wasekhaya ogxile kuluhlu olupheleleyo lwezisombululo zokhathalelo oluphambili, kunye neshishini lokuqala laseTshayina ukungena kwiZizwe eziManyeneyo kunye nekhathalogu yokuthengwa kwemveliso yeBhanki yeHlabathi.Umhlalutyi wegazi we-microfluidic hemoglobin oqalwe ekhaya uphumelele kakhulu kwimarike yehlabathi kwaye uKonsung kuphela komenzi waseTshayina ongene kweli candelo.
U-Konsung uzibophelele kubuchwephesha obuphezulu bezonyango kwaye uzuze ukhathalelo oluphambili lwehlabathi.Ukutyhubela iminyaka emininzi yophando kunye nokuqokelelwa kophuhliso, siye safumana itekhnoloji yokuhlalutya igazi elipheleleyo, itekhnoloji ye-multi-wavelength yolwahlulo lwexesha lokuphinda-phinda, i-microfluidic quantification kunye neteknoloji yemveliso yobuninzi, kwaye yaqonda indibaniselwano egqibeleleyo yokusebenza okuphezulu, iindleko eziphantsi kunye ukufumaneka okuphambili kobuchwepheshe be-biochemical eyomileyo.UWang Qiang, i-CEO yaseKonsung, uthe: “Intsebenziswano ne-FUMANA ayibonisi nje kuphela isakhono sokwandisa imarike ye-Konsung, kodwa ikwabonisa amandla ophando lwenzululwazi ka-Konsung.Kuyathenjwa ukuba singawanceda amazwe anengeniso ephantsi kunye nephakathi ukuba afumane itekhnoloji yokuxilongwa ngokufanelekileyo kunye nonyango ngokukhawuleza ngokwabelana ngezibonelelo kunye nolwazi kule ntsebenziswano. "
Ixesha lokuposa: Sep-30-2022